Activating sirtuin 1 significantly increases the depletion of nicotinamide adenine dinucleotide (NAD+) levels in IDH-mutant tumor cells, which rely heavily on NAD+ for survival [58]. The gene discussed is IDH1; the disease is neoplasm.